Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04664556 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

National, Non Interventional Study of Invasive Pneumococcal Disease in Children and Newborns

Study acronym: IPD
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Enrollment target: 1369 to 2500
    • Study description expanded, about 31 words
    • Study title expanded, about 8 words
    • Eligibility criteria expanded, about 3 words
    v6
  2. Re-verified, no change to tracked fieldsv5
  3. Start date: Jan 1, 2010 to Dec 13, 2010
    • Enrollment target: 1205 to 1369
    • Eligibility criteria expanded, about 14 words
    v4
  4. Re-verified, no change to tracked fieldsv3
  5. Collaborators expanded, about 1 wordv2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
After 7 then 13 valent pneumococcal conjugate vaccine (PCV) implementation in France in children, we will evaluate the impact of this vaccination on invasive pneumococcal disease (IPD). We will describe the clinical characteristics of IPD, pneumococcus serotyping, underlying conditions and vaccination status.
Trial Details
NCT Number NCT04664556
Lead Sponsor Association Clinique Thérapeutique Infantile du val de Marne
Collaborators: Pfizer
Conditions
(from sponsor)		 Pneumococcal Infections, Pneumococcal Conjugate Vaccine, Antibiotic Treatment, Mortality
Related terms Pneumococcal Infections
Enrollment 2,500 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov